Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:37:535-546.
doi: 10.1200/EDBK_175437.

Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice

Affiliations
Review

Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice

Elaine S Jaffe et al. Am Soc Clin Oncol Educ Book. 2017.

Abstract

Improved delineation of lymphoid malignancy biology has prompted refinement of the 2008 World Health Organization (WHO) classification of hematopoietic and lymphoid tumors with a new framework introduced in 2016. This knowledge has provided valuable insights regarding management. Early clonal proliferations have been set apart given their limited potential for malignant dissemination. Increasing knowledge of molecular drivers of aggressive lymphomas has allowed subclassification and opportunity for clinical investigations to personalize therapy. New insights into T-cell pathophysiology has allowed grouping based on shared molecular and cellular features. This article will summarize the key changes in terms of diagnosis and histopathologic definitions, the impact of these changes on clinical management, and the challenges of future research in this field.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest provided by the authors are available with the online article at asco.org/edbook.

Figures

FIGURE 1.
FIGURE 1.
Navigating Changes in the Classification of Aggressive B-Cell Lymphomas, 2008 to 2016.

References

    1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–1392. - PubMed
    1. Jaffe ES, Harris NL, Stein H, et al. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues Lyon, France: IARC Press; 2001.
    1. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835–3849. - PubMed
    1. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Ed. Lyon, France: International Agency for Research on Cancer; 2008.
    1. Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011;117:5019–5032. - PMC - PubMed

LinkOut - more resources